SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001703057-24-000026
Filing Date
2024-02-27
Accepted
2024-02-27 14:12:58
Documents
1
Period of Report
2024-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709061178.html 4  
1 FORM 4 wk-form4_1709061178.xml 4 6508
  Complete submission text file 0001703057-24-000026.txt   7944
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address
Hansen Carl L. G. (Reporting) CIK: 0001834412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 24685212